EHCNYSEServices-HospitalsFiscal year ends December 31
Encompass Health Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$121.71−6.16 (-4.82%)
Close on Oct 19, 2026
- Market cap
- $12.17B
- P/E (TTM)
- 19.8
- Dividend yield
- 0.59%
Encompass Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Hospitals companies for comparison
Valuation
| Measure | Encompass Health | Industry median |
|---|---|---|
| Market Cap | $12.01B | $1.11B |
| Enterprise Value | $15.34B | $1.41B |
| PE Ratio | 19.82 | 22.72 |
| PS Ratio | 1.93 | 1.60 |
| PB Ratio | 4.62 | 3.03 |
| P/TBV Ratio | 12.41 | 4.99 |
| P/FCF Ratio | 29.04 | 20.54 |
| P/OCF Ratio | 9.90 | 15.44 |
Enterprise value
| Measure | Encompass Health | Industry median |
|---|---|---|
| EV / Sales | 2.47 | 1.69 |
| EV / EBITDA | 10.23 | 14.40 |
| EV / FCF | 37.10 | 23.16 |
Income (trailing twelve months)
| Measure | Encompass Health | Industry median |
|---|---|---|
| Revenue | $6.21B | $561.90M |
| Pretax Income | $1.03B | -$572.42K |
| Net Income | $621.00M | -$1.16M |
| EBITDA | $1.50B | -$20.72K |
| EPS (Diluted) | $6.14 | -$0.02 |
Margins
| Measure | Encompass Health | Industry median |
|---|---|---|
| Pretax Margin | 16.6% | 1.54% |
| Profit Margin | 10.0% | -2.91% |
| EBITDA Margin | 24.2% | 2.41% |
| FCF Margin | 6.66% | 3.13% |
Returns
| Measure | Encompass Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | 25.5% | 1.84% |
| Return on Assets (ROA) | 8.72% | -3.06% |
Growth
| Measure | Encompass Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 9.47% | 6.92% |
| Net Income Growth (YoY) | 18.8% | 19.6% |
| EPS Growth (YoY) | 20.2% | 25.8% |
| FCF Growth (YoY) | -5.87% | -6.04% |
| Revenue Growth (3Y CAGR) | 10.9% | 10.9% |
| Revenue Growth (5Y CAGR) | 10.7% | 13.2% |
| EPS Growth (3Y CAGR) | 27.1% | 19.8% |
| EPS Growth (5Y CAGR) | 14.2% | 9.29% |
Balance sheet
| Measure | Encompass Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $107.70M | $48.71M |
| Total Debt | $2.63B | $140.00M |
| Net Cash (Debt) | -$2.53B | $205.49K |
| Net Cash Per Share | -$25.61 | $0.01 |
| Equity (Book Value) | $2.60B | $235.16M |
| Book Value Per Share | $26.33 | $3.48 |
| Tangible Book Value | $967.40M | $703.69K |
| Working Capital | $167.60M | $30.48M |
Financial position
| Measure | Encompass Health | Industry median |
|---|---|---|
| Current Ratio | 1.19 | 1.40 |
| Quick Ratio | 0.91 | 1.02 |
| Debt / Equity | 1.01 | 0.66 |
| Debt / EBITDA | 1.76 | 2.61 |
| Debt / FCF | 6.37 | 4.59 |
| Net Debt / EBITDA | 1.68 | 2.15 |
Cash flow (trailing twelve months)
| Measure | Encompass Health | Industry median |
|---|---|---|
| Operating Cash Flow | $1.21B | $3.10M |
| Capital Expenditures | -$799.10M | -$18.62M |
| Free Cash Flow | $413.40M | $23.73M |
| FCF Per Share | $4.19 | $0.37 |
Efficiency
| Measure | Encompass Health | Industry median |
|---|---|---|
| Asset Turnover | 0.87 | 0.87 |
| Revenue Per Employee | $147.76K | $228.48K |
| Profits Per Employee | $14.79K | -$5.75K |
| Employee Count | 42,000 | 910 |
Dividends and yields
| Measure | Encompass Health | Industry median |
|---|---|---|
| Earnings Yield | 5.17% | -0.59% |
| FCF Yield | 3.44% | 1.74% |
| Dividend Yield | 0.59% | 0.61% |
| Buyback Yield | 2.06% | 0.32% |
| Shareholder Yield | 2.65% | 0.65% |
| Dividend Per Share | $0.72 | $1.30 |
| Dividend Growth (YoY) | 12.5% | 4.55% |
| Years of Dividend Growth | 2 | 4 |
| Payout Ratio | 12.1% | 14.1% |
| FCF Payout Ratio | 18.2% | 12.0% |
Shares
| Measure | Encompass Health | Industry median |
|---|---|---|
| Shares Outstanding | 98,653,400 | 58,282,400 |
| Shares Change (YoY) | -0.95% | 2.68% |
| Float | 97,648,100 | 33,780,100 |
| Shares Held by Insiders | 1.02% | 16.4% |
| Shares Held by Institutions | 97.0% | 85.9% |
Taxes
| Measure | Encompass Health | Industry median |
|---|---|---|
| Income Tax | $210.30M | $697.00K |
| Effective Tax Rate | 20.5% | 23.1% |
Scores
| Measure | Encompass Health | Industry median |
|---|---|---|
| Graham Number | $60.31 | $19.59 |
| Graham Upside | -50.4% | -47.5% |
| Altman Z-Score | 2.66 | 2.05 |
| Piotroski F-Score | 8 | 5 |
Calculated by StockData from Encompass Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.